🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the antitumor efficacy of crenolan...
Status
Terminated
Location
Harold Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center
Start Date
2011-04
Trial ID
NCT01229644
Treatments Being Tested
This is a Phase II open label study of crenolanib besylate. This study will...
Status
Completed
Location
University of Texas Southwestern Medical Center
Start Date
2012-07
Trial ID
NCT01522469
Treatments Being Tested
This is a single-arm, Phase II study of crenolanib as maintenance in AML pa...
Status
Completed
Location
MD Anderson Cancer Center
Start Date
2015-09
Trial ID
NCT02400255
Treatments Being Tested
This pilot Phase II study is designed to evaluate the efficacy and tolerabi...
Status
Completed
Location
MD Anderson Cancer Center
Start Date
2012-10
Trial ID
NCT01657682
Treatments Being Tested
Compassionate use of crenolanib for patients with serious life-threatening ...
Status
Available
Location
Ospedale Policlinico San Martino
Start Date
TBD
Trial ID
NCT03620318
Treatments Being Tested
This is a phase II, multicenter, single-arm study to assess the safety and ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-01
Trial ID
NCT03324243
Treatments Being Tested
A phase III randomized multi-center study designed to compare the efficacy ...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2018-08-15
Trial ID
NCT03258931
Treatments Being Tested
This is an open label, two-arm, Phase I-II trial, non-randomized. Arm 1: cr...
Status
Completed
Location
MD Anderson Cancer Center
Start Date
2015-09
Trial ID
NCT02400281
Treatments Being Tested
This is a multicenter, randomized, double-blinded, placebo-controlled, tria...
Status
Unknown
Location
Sarcoma Oncology Center
Start Date
2016-08
Trial ID
NCT02847429
Treatments Being Tested
This Phase II study is designed to evaluate the antitumor efficacy and phar...
Status
Completed
Location
Knight Cancer Institute, Oregon Health and Science University
Start Date
2011-04
Trial ID
NCT01243346
Treatments Being Tested